Kalvista Pharmaceuticals Inc(KALV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KALV Kalvista Pharmaceuticals Inc

未开盘 11-21 16:00:00 EST

9.33

+0.37

+4.07%

盘后9.33

+0.000.00%

17:41 EST

最高9.33	最低8.75	成交量49.33万
今开9.02	昨收8.96	日振幅6.47%
总市值4.59亿	流通市值2.98亿	总股本4,922万
成交额447.53万	换手率1.54%	流通股本3,195万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KALV","market":"US","secType":"STK","nameCN":"Kalvista Pharmaceuticals Inc","latestPrice":9.325,"timestamp":1732222800000,"preClose":8.96,"halted":0,"volume":493279,"hourTrading":{"tag":"盘后","latestPrice":9.325,"preClose":9.325,"latestTime":"17:41 EST","volume":6872,"amount":64098.375,"timestamp":1732228909951},"delay":0,"floatShares":31948000,"shares":49215472,"eps":-3.567324,"marketStatus":"未开盘","marketStatusCode":0,"change":0.365,"latestTime":"11-21 16:00:00 EST","open":9.02,"high":9.33,"low":8.75,"amount":4475288.032590999,"amplitude":0.064732,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.567324,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"listingDate":1479790800000,"adjPreClose":8.96,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":9.325,"preClose":9.325,"latestTime":"17:41 EST","volume":6872,"amount":64098.375,"timestamp":1732228909951},"volumeRatio":0.78477,"impliedVol":0.6993,"impliedVolPercentile":0.3147},"requestUrl":"/m/hq/s/KALV","defaultTab":"news","newsList":[{"id":"2484418676","title":"Kalvista Pharmaceuticals, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484418676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484418676?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:45","pubTimestamp":1731941115,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时45分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.16%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Hcw Biologics Inc.、冠科美博、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为543.01%、355.44%、257.01%，振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为118.81%、62.38%、42.18%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822451598e43439&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822451598e43439&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2483333750","title":"Kalvista Pharmaceuticals, Inc.盘中异动 股价大跌5.07%报9.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483333750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483333750?lang=zh_cn&edition=full","pubTime":"2024-11-15 02:49","pubTimestamp":1731610184,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日02时49分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.07%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃，换手率分别为4387.04%、3307.80%、383.65%，振幅较大的相关个股有Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为249.67%、211.36%、188.46%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115024944971a69fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115024944971a69fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2481855869","title":"Kalvista Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.60%报11.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481855869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481855869?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:34","pubTimestamp":1730903653,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时34分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.60%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1070.77%、103.20%、54.59%，振幅较大的相关个股有Lakeshore Biopharma Co., Ltd、Inmed Pharmaceuticals Inc.、Immunitybio, Inc.，振幅分别为107.44%、106.04%、105.49%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622341395bddbeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622341395bddbeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2480581658","title":"Kalvista Pharmaceuticals, Inc.盘中异动 股价大涨6.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581658?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:32","pubTimestamp":1730730755,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时32分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价大幅上涨6.88%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Neurogene Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为234.99%、129.82%、43.00%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd.，振幅分别为29.83%、22.67%、12.78%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422323595bdc9fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422323595bdc9fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2478212484","title":"Kalvista Pharmaceuticals, Inc.盘中异动 大幅上涨5.31%报12.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478212484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478212484?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:24","pubTimestamp":1730125465,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时24分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.31%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Monte Rosa Therapeutics, Inc.、Eyepoint Pharmaceuticals, Inc.涨幅较大，Tc Biopharm  Plc、Genprex, Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为629.88%、54.13%、52.37%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.，振幅分别为87.13%、84.14%、46.83%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222426971a2ad2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222426971a2ad2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2472337251","title":"Kalvista Pharmaceuticals, Inc.盘中异动 下午盘急速下跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472337251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472337251?lang=zh_cn&edition=full","pubTime":"2024-10-01 02:12","pubTimestamp":1727719923,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日02时12分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.19%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Nkgen Biotech Inc C/Wts 31/05/2028、Capricor Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Seelos Therapeutics, Inc.、Gri Bio, Inc.较为活跃，换手率分别为214.57%、60.53%、58.02%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Tc Biopharm  Plc C/Wts 10/02/2028 、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为87.30%、85.25%、48.53%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001021204a1ddbcf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001021204a1ddbcf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2467707104","title":"Kalvista Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2467707104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467707104?lang=zh_cn&edition=full","pubTime":"2024-09-14 02:43","pubTimestamp":1726253036,"startTime":"0","endTime":"0","summary":"北京时间2024年09月14日02时43分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.31%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Instil Bio, Inc.、Mbx Biosciences, Inc.、Immuneering Corporation涨幅较大，Windtree Therapeutics, Inc.、Immuneering Corporation、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为1013.35%、442.71%、120.76%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Instil Bio, Inc.、Immuneering Corporation，振幅分别为86.14%、64.53%、51.75%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240914024357a1da3a48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240914024357a1da3a48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","KALV","BK4139","BK4563"],"gpt_icon":1},{"id":"2465542851","title":"卡尔维斯塔制药公司公布截至 7 月 31 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2465542851","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465542851?lang=zh_cn&edition=full","pubTime":"2024-09-05 21:31","pubTimestamp":1725543112,"startTime":"0","endTime":"0","summary":"   * Kalvista Pharmaceuticals Inc   报告，截至7月31日的季度调整后每股亏损87美分，低于去年同期的每股收益-74美分。五位分析师对该季度的平均预期是每股亏损 91 美分。华尔街预期为每股亏损 1.02 美元至-80 美分。* Kalvista Pharmaceuticals Inc 公布的季度每股收益为亏损 87 美分。* 该公司当季亏损 4,044 万美元。* Kalvista Pharmaceuticals Inc 的股价本季度上涨了 9.7%，今年迄今为止上涨了 5.5%。华尔街对 Kalvista Pharmaceuticals Inc 的 12 个月目标价中位数为 32.00 美元。本摘要由 LSEG 9 月 5 日 01:31 p.m. UTC 的调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"卡尔维斯塔制药公司公布截至 7 月 31 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2464802616","title":"Kalvista Pharmaceuticals Inc   预计每股亏损 91 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2464802616","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464802616?lang=zh_cn&edition=full","pubTime":"2024-09-03 21:59","pubTimestamp":1725371962,"startTime":"0","endTime":"0","summary":"   * Kalvista Pharmaceuticals Inc    预计在9月5日公布截至2024年7月31日的业绩时，季度收入将不会有任何变化(预计)。*    * LSEG分析师对Kalvista Pharmaceuticals Inc的平均预期是每股亏损91美分。* 华尔街对 Kalvista Pharmaceuticals Inc 的 12 个月目标价中位数为 32.00 美元，高于其上次收盘价 13.39 美元。9月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Kalvista Pharmaceuticals Inc   预计每股亏损 91 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV"],"gpt_icon":0},{"id":"2459959408","title":"Kalvista Pharmaceuticals, Inc.盘中异动 大幅拉升5.12%报13.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459959408","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459959408?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:46","pubTimestamp":1723740383,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日00时46分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.12%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.47%。其相关个股中，Cingulate Inc.、Nutriband Inc C/Wts 、Tempest Therapeutics, Inc.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为7847.47%、2251.32%、621.92%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nutriband Inc C/Wts 、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为163.00%、115.79%、103.98%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816004624a1d47664&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816004624a1d47664&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2458034090","title":"Kalvista Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458034090","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458034090?lang=zh_cn&edition=full","pubTime":"2024-08-09 01:43","pubTimestamp":1723138994,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日01时43分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.04%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为3.17%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Senti Biosciences, Inc.、Aldeyra Therapeutics, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Aditxt, Inc.较为活跃，换手率分别为424.96%、296.53%、199.25%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为131.52%、54.41%、45.58%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809014314941ff831&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809014314941ff831&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2457670773","title":"Kalvista Pharmaceuticals, Inc.盘中异动 股价大跌7.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457670773","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457670773?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:38","pubTimestamp":1722865081,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时38分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价快速跳水7.82%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.94%。其相关个股中，Zevra Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1065.46%、51.14%、14.09%，振幅较大的相关个股有Alterity Therapeutics Limited、Cns Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为20.00%、19.99%、17.59%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052138029f1072ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052138029f1072ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2456450045","title":"Kalvista Pharmaceuticals, Inc.盘中异动 股价大跌5.02%报13.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456450045","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456450045?lang=zh_cn&edition=full","pubTime":"2024-08-02 02:38","pubTimestamp":1722537489,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日02时38分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.02%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Dermata Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃，换手率分别为2837.22%、372.43%、218.22%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Renovaro Inc.、Virax Biolabs Group Limited，振幅分别为59.30%、57.88%、43.37%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802023809af956791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802023809af956791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2452717436","title":"Kalvista Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌5.01%报14.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452717436","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452717436?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:53","pubTimestamp":1721318029,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时53分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.01%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.02%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为2241.57%、2080.70%、1179.54%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家制药公司，专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235349aefa5a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235349aefa5a66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2451626886","title":"Kalvista Pharmaceuticals, Inc.盘中异动 快速上涨5.14%报13.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451626886","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451626886?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:08","pubTimestamp":1721052536,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日22时08分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.14%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家制药公司，专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂。消息层面，截至22时08分，《Needham维持KalVista Pharmaceuticals买入评级，下调目标价至32美元》资讯为影响Kalvista Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152208569681cd37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152208569681cd37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2450535689","title":"Kalvista Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450535689","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450535689?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:32","pubTimestamp":1720791121,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时32分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.76%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家制药公司，专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂。消息层面，截至21时32分，《Needham维持KalVista Pharmaceuticals买入评级，下调目标价至32美元》资讯为影响Kalvista Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213202aef97a4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213202aef97a4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2450372033","title":"美国研究综述：波士顿啤酒公司、Inter Parfums、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2450372033","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450372033?lang=zh_cn&edition=full","pubTime":"2024-07-12 15:46","pubTimestamp":1720770376,"startTime":"0","endTime":"0","summary":"    路透7月12日 - 华尔街证券分析师周五修订了对波士顿啤酒公司、Inter Parfums 和 Netflix 等几家美国上市公司的评级和目标价。亮点             * 波士顿啤酒公司  ：Piper Sandler 将该公司的目标价从 350 美元下调至 344 美元              * Inter Parfums Inc   ：杰富瑞将其评级从 \"持有 \"上调至 \"买入              * Netflix Inc   ：摩根大通将目标价从650美元上调至750美元              * Smurfit Westrock   ：摩根大通将该股列入分析师关注名单              * Vita Coco Company Inc   ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1153585028.USD","BK4566","NKE","IPAR","LU1046421795.USD","SW","CPAY","ZLAB","SG9999004303.SGD","BK4209","PTLO","SG9999001077.SGD","BK4108","BK4550","IPG","KALV","LU2098885051.SGD","SCHW","WEX","OXY","EL","CPT","BK4558","WES","LU0234572021.USD","CAG","IE00B19Z8W00.USD","BSVN","LU1861220207.SGD","BK4127","BK4009","BK4201","LU0786609619.USD","LU2360107671.USD","WPC","PNTG","BK4177","SAGE","MEI","LU1861217088.USD","SAM","BK4146","LU0266013472.USD","NFLX","IDYA","BK4548","YMAB","PEP","COCO","LU1303367103.USD"],"gpt_icon":0},{"id":"2450365782","title":"KalVista Pharma(KALV.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-1.02美元，前值为-0.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450365782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450365782?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:08","pubTimestamp":1720706931,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2450355739","title":"卡尔维斯塔制药公司公布截至四月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2450355739","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450355739?lang=zh_cn&edition=full","pubTime":"2024-07-11 19:44","pubTimestamp":1720698295,"startTime":"0","endTime":"0","summary":"   * Kalvista Pharmaceuticals Inc   报告，截至4月底的季度调整后每股亏损1.02美元，低于去年同期的每股收益-77美分。六位分析师对该季度的平均预期是每股亏损 73 美分。华尔街预期为每股-84美分至-55美分。* Kalvista Pharmaceuticals Inc 公布的季度每股收益为亏损 1.02 美元。* 该公司当季亏损 4465 万美元。* Kalvista Pharmaceuticals Inc 的股价本季度上涨了 6.7%，今年迄今为止上涨了 2.6%。* 医药同行的平均一致建议是 \"买入\"。华尔街对 Kalvista Pharmaceuticals Inc 的 12 个月目标价中位数为 35.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2448028321","title":"Kalvista Pharmaceuticals Inc   预计每股亏损73美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2448028321","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448028321?lang=zh_cn&edition=full","pubTime":"2024-07-03 20:32","pubTimestamp":1720009941,"startTime":"0","endTime":"0","summary":"   * Kalvista Pharmaceuticals Inc    预计在7月5日公布截至2024年4月30日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对Kalvista Pharmaceuticals Inc的平均预期是每股亏损73美分。* 华尔街对 Kalvista Pharmaceuticals Inc 的 12 个月目标价中位数为 35.00 美元，高于其最新收盘价 11.51 美元。7月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kalvista.com","stockEarnings":[{"period":"1week","weight":-0.0485},{"period":"1month","weight":-0.2449},{"period":"3month","weight":-0.2617},{"period":"6month","weight":-0.1748},{"period":"1year","weight":0.2302},{"period":"ytd","weight":-0.2388}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"KalVista Pharmaceuticals, Inc.于2004年3月26日在特拉华州注册成立。该公司是一家临床阶段制药公司，专注于发现、开发和商业化小分子蛋白酶抑制剂，用于有重大未满足需求的疾病。该公司运用他们对蛋白酶的化学和生物学的洞见，开发出具有高选择性、效力和生物利用度的口服疗法，该公司相信这将使它们成为治疗疾病的成功药物。该公司利用这些能力开发了针对遗传性血管性水肿（HAE）的新型小分子血浆激肽释放酶抑制剂。该公司还在进行一项新的口服XIIa因子（“XIIa因子”）抑制剂项目的临床前开发。该公司正在初步推进这一项目，以提供下一代HAE疗法，这也为将来扩展到其他未满足的高需求适应症提供了机会。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.011211},{"month":2,"riseRate":0.5,"avgChangeRate":0.168896},{"month":3,"riseRate":0.375,"avgChangeRate":-0.068789},{"month":4,"riseRate":0.375,"avgChangeRate":0.010157},{"month":5,"riseRate":0.5,"avgChangeRate":-0.027585},{"month":6,"riseRate":0.625,"avgChangeRate":-0.000971},{"month":7,"riseRate":0.5,"avgChangeRate":0.018821},{"month":8,"riseRate":0.625,"avgChangeRate":0.169598},{"month":9,"riseRate":0.25,"avgChangeRate":-0.062258},{"month":10,"riseRate":0.375,"avgChangeRate":0.021922},{"month":11,"riseRate":0.5,"avgChangeRate":0.034544},{"month":12,"riseRate":0.5,"avgChangeRate":0.066364}],"exchange":"NASDAQ","name":"Kalvista Pharmaceuticals Inc","nameEN":"Kalvista Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kalvista Pharmaceuticals Inc(KALV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kalvista Pharmaceuticals Inc(KALV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kalvista Pharmaceuticals Inc,KALV,Kalvista Pharmaceuticals Inc股票,Kalvista Pharmaceuticals Inc股票老虎,Kalvista Pharmaceuticals Inc股票老虎国际,Kalvista Pharmaceuticals Inc行情,Kalvista Pharmaceuticals Inc股票行情,Kalvista Pharmaceuticals Inc股价,Kalvista Pharmaceuticals Inc股市,Kalvista Pharmaceuticals Inc股票价格,Kalvista Pharmaceuticals Inc股票交易,Kalvista Pharmaceuticals Inc股票购买,Kalvista Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kalvista Pharmaceuticals Inc(KALV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kalvista Pharmaceuticals Inc(KALV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}